Chinese Scientists Have Contributed To TheTreatment Of Alzheimer's Disease
China is about to begin clinical trials of a new drug against Alzheimer's disease. Experiments one animals have gone well and allow to move to the next phase of work on the medicine.
The working title of the drug is AD16. Its creators are the employees of the Guangzhou Institute of Biomedicine and Health of the Chinese Academy of Sciences. According to studies, the means can improve memory and cognitive abilities in guinea pigs.
AD16 works as an antiphlogistic agent for neurons and is able to attenuate the negative effect of beta-amyloid protein on the neurons. Thus, it inhibits the development of neurodegenerative diseases. According to statistics, Alzheimer's disease is diagnosed among millions of elderly people worldwide.
Effective medications are still not found. One of the reasons for it is that the scientists still have a little understanding of the origins of the disease. By far almost all of the theory and practice is based on the belief that the disease is caused by deposits of beta-amyloid protein in the brain.
- Alzheimer's Disease: The Role Of Genetic Factors
- Pfizer Stopped Selling Pneumococcal Vaccine in China
- Increased Sugar And Alzheimer's Disease Are Connected